AimsDesmoplastic infantile astrocytoma/ganglioglioma (DIA/DIG) is a rare primary neuroepithelial brain tumour typically affecting paediatric patients younger than 24 months. Knowledge about genetic alterations in DIA/DIG is limited. However, a previous study on BRAF V600E mutation in paediatric glioma revealed a BRAF mutation in one of two tested DIAs/DIGs. The limited number of cases in that study did not allow any conclusion about mutation frequency of BRAF in this tumour entity. MethodsWe collected a series of 18 DIAs/DIGs for testing BRAF V600E mutational status by BRAF V600E immunohistochemistry (clone VE1). Cases with sufficient DNA were tested for BRAF V600E mutation by pyrosequencing. ResultsThree out of 18 DIAs/DIGs presented with VE1 binding. A considerable proportion of BRAF V600E mutated tumour cells was detected in the cortical tumour component, whereas the pronounced leptomeningeal tumoural stroma was predominantly negative for VE1 binding. Pyrosequencing confirmed BRAF V600E mutation in two of three VE1-positive cases. ConclusionBRAF V600E mutation affects a subset of DIAs/DIGs and offers new therapeutic opportunities.

BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma / C., Koelsche; F., Sahm; W., Paulus; M., Mittelbronn; Giangaspero, Felice; Antonelli, Manila; J., Meyer; F., Lasitschka; A., Von Deimling; D., Reuss. - In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. - ISSN 0305-1846. - ELETTRONICO. - 40:3(2014), pp. 337-344. [10.1111/nan.12072]

BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma

GIANGASPERO, FELICE;ANTONELLI, MANILA;
2014

Abstract

AimsDesmoplastic infantile astrocytoma/ganglioglioma (DIA/DIG) is a rare primary neuroepithelial brain tumour typically affecting paediatric patients younger than 24 months. Knowledge about genetic alterations in DIA/DIG is limited. However, a previous study on BRAF V600E mutation in paediatric glioma revealed a BRAF mutation in one of two tested DIAs/DIGs. The limited number of cases in that study did not allow any conclusion about mutation frequency of BRAF in this tumour entity. MethodsWe collected a series of 18 DIAs/DIGs for testing BRAF V600E mutational status by BRAF V600E immunohistochemistry (clone VE1). Cases with sufficient DNA were tested for BRAF V600E mutation by pyrosequencing. ResultsThree out of 18 DIAs/DIGs presented with VE1 binding. A considerable proportion of BRAF V600E mutated tumour cells was detected in the cortical tumour component, whereas the pronounced leptomeningeal tumoural stroma was predominantly negative for VE1 binding. Pyrosequencing confirmed BRAF V600E mutation in two of three VE1-positive cases. ConclusionBRAF V600E mutation affects a subset of DIAs/DIGs and offers new therapeutic opportunities.
2014
desmoplastic infantile ganglioglioma; glioma; braf v600e; immunohistochemistry; ve1; desmoplastic infantile astrocytoma
01 Pubblicazione su rivista::01a Articolo in rivista
BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma / C., Koelsche; F., Sahm; W., Paulus; M., Mittelbronn; Giangaspero, Felice; Antonelli, Manila; J., Meyer; F., Lasitschka; A., Von Deimling; D., Reuss. - In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. - ISSN 0305-1846. - ELETTRONICO. - 40:3(2014), pp. 337-344. [10.1111/nan.12072]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/650093
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 35
social impact